Special Report

30 Most Anticipated Products Coming in 2018

Source: Courtesy of HarperCollins Publishers

Brave by Rose McGowan
> Category: Books
> Expected release date: January 30
> Publisher: HarperCollins Publishers

With countless, widely successful men in media recently dethroned from the spotlight after accusations of sexual harassment, this book is bound to be a hit. Rose McGowan is one of several women who recently came forward and accused film mogul Harvey Weinstein of sexual misconduct. In her memoir, “Brave,” McGowan touches upon the nightmares of stardom and sexualization in Hollywood.

Source: Alberto E. Rodriguez / Getty Images

The Winds of Winter by George R.R. Martin
> Category: Books
> Expected release date: TBA
> Publisher: Bantam Books

This one is for A Song of Ice and Fire fans. 2018 could be the year that George R.R. Martin finally delivers the sixth book in his epic fantasy novel series that spawned the HBO smash hit TV show Game of Thrones. With the show likely taking up much of Martin’s attention, fans have been clamoring for “The Winds of Winter” for years. Martin said fans could likely expect a Westeros book in 2018, but that’s the same thing he said about 2017 — so we’ll just have to wait and see.

Source: Courtesy of BMW

New BMW 3 Series
> Category: Cars
> Expected release date: Mid-2018
> Manufacturer: BMW

The 3 Series from BMW is often considered the standard for sports sedans, but some outlets like Car and Driver feel the vehicle has fallen off the pace of its competition lately. But BMW hopes to reclaim its crown with the new redesigned 3 Series, due out in 2018.

Source: Courtesy of Dodge

Dodge Challenger SRT Demon
> Category: Cars
> Expected release date: Summer 2018
> Manufacturer: Fiat Chrysler Automobiles

If you like going fast, you may want to check out the Dodge Challenger SRT Demon. Dodge claims it can go from zero to 100 mph in 2.3 seconds, faster than any other production car on the market — and faster than some exotic cars costing over $1 million.

Source: Ridofranz / iStock

> Category: Medical treatments
> Expected release date: TBA
> Manufacturer: Gilead

Though HIV currently has no cure, the scientific and medical communities continue to work on treatments to improve the lives and health of people living with HIV/AIDS. Many are hopeful that Bictegravir/F/TAF can prevent the virus from multiplying within the body of infected patients. Now that the drug has received FDA approval, it could hit the market soon.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.